Stockscreener 앱 받기
16.96
2.76%
0.455
전일 마감가:
$16.51
열려 있는:
$16.88
하루 거래량:
14,077
Relative Volume:
0.27
시가총액:
$321.02M
수익:
$54,000
순이익/손실:
$-210.26M
주가수익비율:
-21.47
EPS:
-0.79
순현금흐름:
$-159.01M
1주 성능:
-4.96%
1개월 성능:
+32.33%
6개월 성능:
+93.44%
1년 성능:
-28.11%
1일 변동 폭
$16.37
$17.01
1주일 범위
$16.37
$19.45
52주 변동 폭
$7.65
$30.00
Lyell Immunopharma Inc Stock (LYEL) Company Profile
명칭
Lyell Immunopharma Inc
전화
650 695-0677
주소
201 HASKINS WAY, SOUTH SAN FRANCISCO
LYEL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LYEL
Lyell Immunopharma Inc
|
16.71 | 317.18M | 54,000 | -210.26M | -159.01M | -0.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
472.71 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.21 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
801.26 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
331.58 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Lyell Immunopharma Inc Stock (LYEL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-10-30 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2024-06-27 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2023-08-28 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-11-14 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-11-11 | 다운그레이드 | Goldman | Buy → Neutral |
| 2022-10-17 | 개시 | H.C. Wainwright | Buy |
| 2021-07-12 | 개시 | BofA Securities | Buy |
| 2021-07-12 | 개시 | Goldman | Buy |
| 2021-07-12 | 개시 | JP Morgan | Overweight |
| 2021-07-12 | 개시 | Morgan Stanley | Overweight |
모두보기
Lyell Immunopharma Inc 주식(LYEL)의 최신 뉴스
Tick level data insight on Lyell Immunopharma Inc. volatilityPortfolio Value Report & Free Safe Entry Trade Signal Reports - newser.com
Is it too late to sell Lyell Immunopharma Inc.Market Trend Review & Expert-Curated Trade Recommendations - newser.com
How to track smart money flows in Lyell Immunopharma Inc.Portfolio Gains Report & Consistent Income Trade Ideas - newser.com
Is Lyell Immunopharma Inc. showing signs of accumulationMarket Movement Recap & Expert Curated Trade Setup Alerts - newser.com
Is Lyell Immunopharma Inc. forming a reversal pattern2025 Market WrapUp & Long-Term Capital Growth Strategies - newser.com
Lyell Immunopharma (NASDAQ:LYEL) Receives "Sell (D-)" Rating from Weiss Ratings - MarketBeat
Will Lyell Immunopharma Inc. continue its uptrend2025 Market Outlook & Risk Managed Investment Signals - newser.com
Clarius Group LLC Reduces Stake in Lyell Immunopharma, Inc. $LYEL - MarketBeat
Can trapped investors hope for a rebound in Lyell Immunopharma Inc.Long Setup & Technical Pattern Alert System - newser.com
Johnson & Johnson Reduces Stock Holdings in Lyell Immunopharma, Inc. $LYEL - MarketBeat
Smart tools for monitoring Lyell Immunopharma Inc.’s price actionPortfolio Update Summary & Long-Term Safe Investment Plans - newser.com
News impact scoring models applied to Lyell Immunopharma Inc.July 2025 Fed Impact & Technical Buy Zone Confirmations - newser.com
Technical analysis overview for Lyell Immunopharma Inc. stockGlobal Markets & High Conviction Trade Alerts - newser.com
Trend analysis for Lyell Immunopharma Inc. this weekProduct Launch & Free Community Supported Trade Ideas - newser.com
Applying chart zones and confluence areas to Lyell Immunopharma Inc.Earnings Overview Report & Capital Efficiency Focused Strategies - newser.com
Will Lyell Immunopharma Inc. stock deliver long term returns2025 Earnings Impact & High Accuracy Investment Signals - newser.com
Using Ichimoku Cloud for Lyell Immunopharma Inc. technicals2025 Stock Rankings & Community Trade Idea Sharing Platform - newser.com
How moving averages guide Lyell Immunopharma Inc. tradingPortfolio Growth Summary & High Accuracy Swing Entry Alerts - newser.com
Voya Investment Management LLC Sells 2,606 Shares of Lyell Immunopharma, Inc. $LYEL - Defense World
Applying Elliott Wave Theory to Lyell Immunopharma Inc.Market Risk Analysis & Consistent Profit Trading Strategies - newser.com
Goldman Sachs Group Inc. Has $193,000 Position in Lyell Immunopharma, Inc. $LYEL - Defense World
What’s the recovery path for long term holders of Lyell Immunopharma Inc.Weekly Loss Report & Consistent Return Investment Signals - newser.com
Lyell Immunopharma Inc (LYEL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Lyell Immunopharma Inc 주식 (LYEL) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Hill Stephen J. | Chief Operating Officer |
Aug 21 '25 |
Sale |
10.54 |
1,004 |
10,586 |
15,845 |
| Newton Charles W. | Chief Financial Officer |
Aug 21 '25 |
Sale |
10.54 |
1,453 |
15,320 |
15,306 |
| Lee Gary K. | Chief Scientific Officer |
Aug 21 '25 |
Sale |
10.54 |
1,453 |
15,320 |
15,504 |
| Seely Lynn | President and CEO |
Aug 12 '25 |
Sale |
10.34 |
406 |
4,197 |
34,828 |
| Seely Lynn | President and CEO |
Aug 11 '25 |
Sale |
10.53 |
391 |
4,116 |
35,234 |
| Hill Stephen J. | Chief Operating Officer |
Aug 12 '25 |
Sale |
10.34 |
94 |
972 |
8,849 |
| Hill Stephen J. | Chief Operating Officer |
Aug 11 '25 |
Sale |
10.53 |
91 |
958 |
8,943 |
| Lee Gary K. | Chief Scientific Officer |
Aug 12 '25 |
Sale |
10.34 |
136 |
1,406 |
8,957 |
| Lee Gary K. | Chief Scientific Officer |
Aug 11 '25 |
Sale |
10.53 |
131 |
1,379 |
9,093 |
| Newton Charles W. | Chief Financial Officer |
Aug 12 '25 |
Sale |
10.34 |
136 |
1,406 |
8,759 |
1.19%
자본화:
|
볼륨(24시간):